{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:43:17Z","timestamp":1794652997803,"version":"4.9.1"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.antiviral.2020.104824","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:20:31Z","timestamp":1590146431000},"page":"104824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":195,"special_numbering":"C","title":["Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential"],"prefix":"10.1016","volume":"180","author":[{"given":"Yuchen","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104824_bib1","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1128\/JVI.76.12.6356-6363.2002","article-title":"Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication","volume":"76","author":"Addison","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","article-title":"Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo","volume":"67","author":"Allweiss","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2020.104824_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2013.10.021","article-title":"Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration","volume":"60","author":"Allweiss","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2020.104824_bib5","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104824_bib6","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/JVI.02574-12","article-title":"Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription","volume":"87","author":"Benhenda","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/mt.2013.170","article-title":"Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases","volume":"21","author":"Bloom","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2020.104824_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01703079","article-title":"Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell","volume":"8","author":"Bock","year":"1994","journal-title":"Virus Gene."},{"key":"10.1016\/j.antiviral.2020.104824_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104824_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/infdis\/jiz143","article-title":"Comparative analysis of the antiviral effects mediated by type I and III interferons in hepatitis B virus-infected hepatocytes","volume":"220","author":"Bockmann","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104824_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2016.05.014","article-title":"Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients","volume":"65","author":"Boyd","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"Braconi","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7110533","article-title":"Replenishment of hepatitis B virus cccDNA pool is restricted by baseline expression of host restriction factors in vitro","volume":"7","author":"Brezgin","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.antiviral.2020.104824_bib15","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/AAC.00473-12","article-title":"Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation","volume":"56","author":"Cai","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104824_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/mt.2013.212","article-title":"An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases","volume":"22","author":"Chen","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2020.104824_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/viro.1994.1627","article-title":"Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3","volume":"205","author":"Chen","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104824_bib18","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1096\/fj.11-187781","article-title":"A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication","volume":"25","author":"Chen","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.antiviral.2020.104824_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/dna.1998.17.951","article-title":"Insulin activates the hepatitis B virus X gene through the activating protein-1 binding site in HepG2 cells","volume":"17","author":"Choi","year":"1998","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104824_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.05.003","article-title":"Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome","volume":"144","author":"Chong","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib21","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1073\/pnas.85.21.7937","article-title":"Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters","volume":"85","author":"Courtois","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104824_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2010.20","article-title":"Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs","volume":"18","author":"Cradick","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2020.104824_bib23","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1128\/JVI.01481-15","article-title":"Alteration of mature nucleocapsid and enhancement of covalently closed circular DNA formation by hepatitis B virus core mutants defective in complete-virion formation","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib24","doi-asserted-by":"crossref","first-page":"11494","DOI":"10.1128\/JVI.01912-13","article-title":"Maturation-associated destabilization of hepatitis B virus nucleocapsid","volume":"87","author":"Cui","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128401","article-title":"Does tyrosyl DNA phosphodiesterase-2 play a role in hepatitis B virus genome repair?","volume":"10","author":"Cui","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104824_bib26","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.celrep.2017.08.008","article-title":"SAMHD1 promotes DNA end resection to facilitate DNA repair by homologous recombination","volume":"20","author":"Daddacha","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2020.104824_bib27","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1093\/nar\/gku260","article-title":"Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1alpha","volume":"42","author":"Dai","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104824_bib29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/MCB.24.4.1799-1808.2004","article-title":"Enhancer I predominance in hepatitis B virus gene expression","volume":"24","author":"Doitsh","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104824_bib30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2020.104824_bib31","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1128\/JVI.02721-06","article-title":"Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein","volume":"81","author":"Gao","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2017.04.012","article-title":"Current treatment guidelines of chronic hepatitis B: the role of nucleos(t)ide analogues and peginterferon","volume":"31","author":"Ghany","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.antiviral.2020.104824_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/1381612822666160527154757","article-title":"Targeting cancer with epi-drugs: a precision medicine perspective","volume":"17","author":"Gherardini","year":"2016","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104824_bib34","first-page":"2","article-title":"Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model","volume":"66","author":"Gilmore","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib35","first-page":"1","article-title":"In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus","volume":"66","author":"Gilmore","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/humu.22087","article-title":"SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutieres syndrome-associated mutations","volume":"33","author":"Goncalves","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.antiviral.2020.104824_bib37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104824_bib38","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.24441","article-title":"MicroRNAs-372\/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I\/B","volume":"54","author":"Guo","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/JVI.01921-09","article-title":"Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib42","first-page":"443","article-title":"Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation","volume":"13","author":"Guo","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104824_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/epi.6.6.15815","article-title":"HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state","volume":"6","author":"Guo","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.antiviral.2020.104824_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib45","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1128\/JVI.74.20.9471-9478.2000","article-title":"The binding site of transcription factor YY1 is required for intramolecular recombination between terminally repeated sequences of linear replicative hepatitis B virus DNA","volume":"74","author":"Hayashi","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib46","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01032-19","article-title":"Revisiting hepatitis B virus: challenges of curative therapies","volume":"93","author":"Hu","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib48","article-title":"MicroRNA-141 represses HBV replication by targeting PPARA","volume":"7","author":"Hu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104824_bib49","article-title":"Rapid turnover of HBV cccDNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic hepatitis B patients","author":"Huang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib50","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104824_bib51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbrc.2012.12.071","article-title":"MicroRNA-501 promotes HBV replication by targeting HBXIP","volume":"430","author":"Jin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104824_bib52","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/JVI.07137-11","article-title":"In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase","volume":"86","author":"Jones","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib53","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1172\/JCI93024","article-title":"Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection","volume":"127","author":"Kah","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2020.104824_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13148-018-0441-z","article-title":"Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins","volume":"10","author":"Khan","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.antiviral.2020.104824_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007124","article-title":"Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus","volume":"14","author":"Kitamura","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104824_bib56","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2017.10.017","article-title":"Efficacy of NVR 3-778, alone and in combination with pegylated interferon, vs entecavir in uPA\/SCID mice with humanized livers and HBV infection","volume":"154","author":"Klumpp","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2012.09.023","article-title":"Snapshots: chromatin control of viral infection","volume":"435","author":"Knipe","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104824_bib58","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels","volume":"69","author":"Ko","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2018.03.027","article-title":"Nonlytic lymphocytes engineered to express virus-specific T-cell receptors limit HBV infection by activating APOBEC3","volume":"155","author":"Koh","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib60","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/jvh.12240","article-title":"Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA","volume":"21","author":"Kohno","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2020.104824_bib61","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses","volume":"111","author":"Koniger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104824_bib62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2013.04.047","article-title":"T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice","volume":"145","author":"Krebs","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib63","doi-asserted-by":"crossref","first-page":"11916","DOI":"10.1128\/JVI.05373-11","article-title":"Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus","volume":"85","author":"Lentz","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fcimb.2017.00091","article-title":"Removal of integrated hepatitis B virus DNA using CRISPR-Cas9","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104824_bib65","article-title":"Distribution of hepatitis B virus nuclear DNA","volume":"92","author":"Li","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib66","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1038\/s41598-017-13082-z","article-title":"IFN-alpha-mediated base excision repair pathway correlates with antiviral response against hepatitis B virus infection","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104824_bib67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2016.08.026","article-title":"Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA","volume":"134","author":"Liu","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib69","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1128\/JVI.03116-14","article-title":"Regulation of multiple stages of hepadnavirus replication by the carboxyl-terminal domain of viral core protein in trans","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.gastro.2008.10.029","article-title":"MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells","volume":"136","author":"Liu","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib71","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/hep.29323","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"66","author":"Lok","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104824_bib73","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1073\/pnas.87.13.5069","article-title":"Multiple liver-specific factors bind to the hepatitis B virus core\/pregenomic promoter: trans-activation and repression by CCAAT\/enhancer binding protein","volume":"87","author":"Lopez-Cabrera","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104824_bib74","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib75","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104824_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00539-17","article-title":"Identification of an intermediate in hepatitis B virus covalently closed circular (CCC) DNA formation and sensitive and selective CCC DNA detection","volume":"91","author":"Luo","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00539-17","article-title":"Identification of intermediate in hepatitis B virus CCC DNA formation and sensitive and selective CCC DNA detection","author":"Luo","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03423-19","article-title":"Involvement of host ATR-CHK1 pathway in hepatitis B virus covalently closed circular DNA formation","volume":"11","author":"Luo","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2020.104824_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008459","article-title":"Role of Hepatitis B virus capsid phosphorylation in nucleocapsid disassembly and covalently closed circular DNA formation","volume":"16","author":"Luo","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104824_bib80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.23611","article-title":"In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice","volume":"52","author":"Lutgehetmann","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib81","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.00393-13","article-title":"Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment","volume":"87","author":"Macovei","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.antiviral.2018.08.014","article-title":"Host functions used by hepatitis B virus to complete its life cycle: implications for developing host-targeting agents to treat chronic hepatitis B","volume":"158","author":"Mitra","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib83","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1038\/s41467-018-06739-4","article-title":"Tridimensional infiltration of DNA viruses into the host genome shows preferential contact with active chromatin","volume":"9","author":"Moreau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104824_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbrc.2014.05.009","article-title":"Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection","volume":"449","author":"Mosca","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104824_bib85","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2020.104824_bib86","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2020.104824_bib87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/viro.1995.1055","article-title":"Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3","volume":"207","author":"Ori","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104824_bib88","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","author":"Polaris Observatory","year":"2018","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib89","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib90","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1093\/nar\/gkr067","article-title":"Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen","volume":"39","author":"Potenza","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib91","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2014.10.001","article-title":"Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient","volume":"62","author":"Qasim","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005893","article-title":"DNA polymerase kappa is a key cellular factor for The formation of covalently closed circular DNA of hepatitis B virus","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104824_bib93","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JVI.02303-05","article-title":"Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events","volume":"80","author":"Rabe","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib94","first-page":"1766","article-title":"Transcription of hepatitis B virus by RNA polymerase II","volume":"3","author":"Rall","year":"1983","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104824_bib95","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104824_bib96","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.75.6.2900-2911.2001","article-title":"Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice","volume":"75","author":"Raney","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib97","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1128\/jvi.66.12.6912-6921.1992","article-title":"Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor","volume":"66","author":"Raney","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib98","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1128\/jvi.69.6.3265-3272.1995","article-title":"Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3","volume":"69","author":"Raney","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29912","article-title":"SIRT3 restricts HBV transcription and replication via epigenetic regulation of cccDNA involving SUV39H1 and SETD1A histone methyltransferases","author":"Ren","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib101","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Riviere","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib102","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01840-18","article-title":"Parvulin 14 and Parvulin 17 bind to HBx and cccDNA and upregulate hepatitis B virus replication from cccDNA to virion in an HBx-dependent manner","volume":"93","author":"Saeed","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib103","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1038\/emi.2013.14","article-title":"T-cell responses in hepatitis B and C virus infection: similarities and differences","volume":"2","author":"Schmidt","year":"2013","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2020.104824_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/v9050125","article-title":"A role for the host DNA damage response in hepatitis B virus cccDNA formation-and beyond?","volume":"9","author":"Schreiner","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104824_bib105","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib106","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.antiviral.2020.104824_bib107","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/mt.2016.94","article-title":"Complete spectrum of CRISPR\/Cas9-induced mutations on HBV cccDNA","volume":"24","author":"Seeger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2020.104824_bib108","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02230-18","article-title":"Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA","volume":"93","author":"Sheraz","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib109","doi-asserted-by":"crossref","first-page":"a021402","DOI":"10.1101\/cshperspect.a021402","article-title":"Hepatitis B virus X and regulation of viral gene expression","volume":"6","author":"Slagle","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"Pt 1","key":"10.1016\/j.antiviral.2020.104824_bib110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1099\/0022-1317-73-1-131","article-title":"Repression of the hepatitis B virus enhancer by a cellular factor","volume":"73","author":"Spandau","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib111","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/jvi.64.6.2819-2824.1990","article-title":"Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification","volume":"64","author":"Summers","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib112","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2020.104824_bib113","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1073\/pnas.98.4.1841","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism","volume":"98","author":"Tang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104824_bib114","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1093\/nar\/gku925","article-title":"Requirement of CRTC1 coactivator for hepatitis B virus transcription","volume":"42","author":"Tang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007742","article-title":"DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA","volume":"15","author":"Tang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104824_bib116","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection: a review","volume":"319","author":"Tang","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.antiviral.2020.104824_bib117","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104824_bib118","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1073\/pnas.88.9.3797","article-title":"Functional analysis of a liver-specific enhancer of the hepatitis B virus","volume":"88","author":"Trujillo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104824_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/v9040075","article-title":"HBV DNA integration: molecular mechanisms and clinical implications","volume":"9","author":"Tu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104824_bib120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib121","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/JVI.02280-09","article-title":"Hepatitis B virus replication induces methylation of both host and viral DNA","volume":"84","author":"Vivekanandan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib122","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S0618-8278(19)30086-6","article-title":"PS-074-A first-in-class orally available HBV cccDNA destabilizer ccc_R08 achieved sustainable HBsAg and HBV DNA suppression in the HBV circle mouse model through elimination of cccDNA-like molecules in the mouse liver","volume":"70","author":"Wang","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib123","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib124","doi-asserted-by":"crossref","first-page":"18484","DOI":"10.1074\/jbc.M113.458158","article-title":"Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a\/miR-16-1 in hepatocytes","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104824_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097579","article-title":"AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication","volume":"9","author":"Weber","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104824_bib126","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41564-020-0678-0","article-title":"Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation","volume":"5","author":"Wei","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.antiviral.2020.104824_bib127","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900355","article-title":"A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis","volume":"2","author":"Wing","year":"2019","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.antiviral.2020.104824_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2020.104824_bib129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2018.02.007","article-title":"Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays","volume":"152","author":"Wu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104824_bib131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.gastro.2018.07.057","article-title":"Development of direct-acting antiviral and host-targeting agents for treatment of hepatitis B virus infection","volume":"156","author":"Xia","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib132","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2018.11.003","article-title":"PASylated interferon alpha efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice","volume":"161","author":"Xia","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib133","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104824_bib134","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2020.104824_bib135","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.7150\/ijms.26125","article-title":"AGK2, A SIRT2 inhibitor, inhibits hepatitis B virus replication in vitro and in vivo","volume":"15","author":"Yu","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.antiviral.2020.104824_bib136","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1128\/jvi.71.12.9366-9374.1997","article-title":"Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily","volume":"71","author":"Yu","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib137","doi-asserted-by":"crossref","first-page":"104619","DOI":"10.1016\/j.antiviral.2019.104619","article-title":"HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription","volume":"172","author":"Yuan","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib138","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2010.08.008","article-title":"Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210","volume":"88","author":"Zhang","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104824_bib139","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.28698","article-title":"RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2\/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis","volume":"64","author":"Zhang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib141","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/hep.23008","article-title":"Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression","volume":"50","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib142","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/hep.24195","article-title":"Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1","volume":"53","author":"Zhang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104824_bib143","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.2033898100","article-title":"Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver","volume":"100","author":"Zhang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104824_bib144","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s00705-014-2208-y","article-title":"miR-125b inhibits hepatitis B virus expression in vitro through targeting of the SCNN1A gene","volume":"159","author":"Zhang","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104824_bib145","doi-asserted-by":"crossref","first-page":"35029","DOI":"10.1074\/jbc.M114.589978","article-title":"MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:39Z","timestamp":1759062699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":145,"alternative-id":["S0166354220302382"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104824","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104824"}}